Our Mitra® devices, powered by our patented VAMS® technology, provide the easiest way to reliably collect a precise volume of biological fluids. Collect Mitra specimens in the field, at home, or on-the-go to generate accurate data for better scientific insights that accelerate research breakthroughs.
Request PricingKeeping Ahead of COVID-19
Learn how to implement remote sampling for SARS-CoV-2 research including vaccine clinical trials, large-scale serology studies, population immunity surveys, cytokine investigations, and more!
Mitra devices are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). The Mitra Microsampling Device is not specific to any clinical test nor does it provide a clinical diagnostic outcome of any nature. Clinical diagnostic laboratories, using the Mitra device for specimen collection, must validate tests according to their organizational needs and comply with relevant regulations.
Our simple, convenient, and economical alternative to traditional specimen collection,microsampling is fueling the virtual revolution in science and research to advance health.
Remote microsampling devices with our patented volumetric sampling technology are the first instruments designed to collect quantitative, volumetrically accurate samples of bio-fluids in a user-friendly manner.
A microsample can be collected by anyone, anywhere and simply mailed via standard post. Over 200 peer-reviewed research publications testify to the power of remote microsampling.
Access Microsampling PublicationsLeading organizations worldwide are using our microsampling technology to power their workflow, advance science, and implement virtual pathways.
We focus on providing user-friendly, accurate microsampling technology to help you reduce the time, energy & resources required to successfully complete projects with maximum return.
With our remote specimen collection kits, we broaden your access to individuals confined to home or populations living in remote rural areas.
With a rapidly growing number of applications that utilize our devices for remote specimen collection, microsampling technology facilitates better insights within shorter timelines.
we created our microsampling devices with you in mind
Whether you are a clinical research participant, lab director, research scientist, clinical trial manager or technician, there is a microsampling device that will work for you. We'll help you select the device format that fits you best via a virtual demonstration with a Microsampling Specialist.
High sample quality, precise volume
(< 4% RSD) collection
Simply touch the Mitra® device tip to a bio fluid and watch it absorb in seconds
Transport specimens without cold-chain shipping. Eliminate freezers for storage.
Send microsamples through the mail and process them in a 96-well format
200+ Mitra research papers illustrate the utility of microsampling technology
Volumetric collection enables precise & quantitative data to be generated
Mitra microsampling offers benefits throughout the drug development pipeline with both large and small molecules - from facilitating serial sampling in animal models for preclinical drug research to offering improved convenience and access in Phase 3 & 4 human trials.
Remote Mitra sampling broadens the subject recruitment pool for large population studies, while its convenience also improves subject compliance & retention.
Remote Mitra sampling enables seroprevalence studies of viral pathogens and insight into associated biomarkers among individuals who remain safely at home during infectious disease outbreaks & social distancing restrictions.
Novel studies of newborns and children is possible with microliter samples that are low-stress and convenient for parents and others to facilitate.
Mitra samples are precise, allowing researchers to accurately capture, analyze genome, proteome, metabolome, and microbiome data from a few drops of biological fluid.
Remote sampling can unlock the potential of precision medicine by enabling longitudinal studies using remote samples to monitor biomarkers in diverse study populations.
In the US, use of the Mitra device is limited to research and non-diagnostic applications. In many countries outside the US, the Mitra device can be used
as a sample collection device for clinical diagnostic applications, as referenced in this content.
“Researchers have considerable experience using these at-home blood collection kits to track the spread of other infectious diseases like influenza, and this method is safe, effective and easy-to-use. With a small finger-pick, volunteers can help scientists fight COVID-19 from their homes.”
– Kaitlyn Sadtler, PhD, Study Lead for Laboratory Testing and Chief, NIH NIBIB’s Section for Immunoengineering, US
“One of the greatest advantages we have been able to appreciate about Mitra® with VAMS® technology is the simplicity and rapidity of use, while maintaining high performance and guaranteeing the reliability of quali-quantitative analytical data."
– Laura Mercolini, PhD, Pharmacy and Biotechnology Research Head, University of Bologna, Italy
We use the blood collection kit at home for our son, who is a kidney transplant recipient. The kit has easy instructions, a finger-prick tool & supplies to collect the samples. We use the included shipping envelopes to post samples to our son’s care provider. The kit saves us time and unnecessary trips to the clinic.”
– Mrs. Lego | Transplant Patient Parent, UK
"VAMS technology allows convenient at-home monitoring and is minimally invasive. It also offers efficiencies in the clinical setting, as providers will have blood results in hand before meeting with the patient."
– Dr. Christophe Stove | Ghent University Hospital, Belgium
"“For our biomarker analysis by chromatography and mass spectrometry using biological samples, the Mitra® with VAMS® technology has allowed us a rapid and effective tuning and validation process, providing a boost to all the optimization steps. In this way, we were able to concentrate on the stability study with a solid and reliable methodology available."
– Michele Protti, Phd, Pharmacy & Biotechnology Research Scientist, University of Bologna, Italy
Simpler, smarter, safer-at-home, and more convenient.
Learn more about our microsampling technologies by exploring our other web pages or get in touch with us!
Request PricingContact Us
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.